India said that the COVID-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and Covishield, from Friday.
Biological E's Corbevax will be available to over 18s as precautionary booster six months after a second dose, the health ministry said in an August 8 letter to state authorities and shared with reporters on Wednesday.
Covishield is produced for the Indian market by the Serum Institute of India under licence from AstraZeneca, while Bharat Biotech makes Covaxin.
India has so far administered more than 2 billion COVID vaccine shots, including 113 million boosters, all of which have so far been of the same vaccine as the recipient's first two doses.
The government says about 89 per cent of people above the age of 12 have had two doses.
The country of nearly 1.4 billion people has documented more than 44 million coronavirus infections and 526,826 related deaths.
The actual numbers are believed to be many times higher.
Trump backs down on strikes on Iran's power network
ICE agents begin deploying at some US airports
Air Canada jet collision shuts LaGuardia; pilots killed, dozens injured
Kuwait launches probe into espionage, state security cases
Trump, Iran threaten to escalate conflict with attacks on energy and water facilities
Fuel reservoir in Russia's Primorsk port on fire after drone attack, governor says
Ambulances from Jewish community organisation torched, UK police say
Israeli airstrikes kill four in Gaza, Palestinian officials say
